Is Ping An Healthcare And Technology (SEHK:1833) Undervalued After Its GlobalCare Launch?

Ping An Healthcare and Technology (SEHK:1833) has put its new Ping An GlobalCare platform in the spotlight by launching a trial in Shenzhen that combines AI-driven real-time medical translation with a fully coordinated online and offline care journey.

Against this product launch, Ping An Healthcare and Technology’s recent share price return has been mixed, with a 7 day gain of 4.02% but a 90 day decline of 10.25% and a year to date fall of 56.48% at a HK$6.345 close. Over a longer horizon, total shareholder return has declined 65.35% over the past year and 62.03% over five years. This frames current enthusiasm around Ping An GlobalCare as part of a wider reassessment of the company’s prospects and risk profile.

Compare Ping An Healthcare and Technology's GlobalCare push with other healthcare AI players by scanning our hand picked 133 healthcare AI stocks that could be building similar real world solutions.

Ping An Healthcare and Technology now trades at a heavy discount to both intrinsic estimates and analyst targets after its sharp slide. Is that a mispricing, or a clear signal that the market’s caution still matches the risks?

Price-to-Earnings of 25.2x: Is it justified for Ping An Healthcare and Technology?

Ping An Healthcare and Technology changes hands at a P/E of 25.2x, which makes the current HK$6.345 share price look cheaper than direct peers on one measure yet richer than both its industry and an estimated fair level on another.

The P/E ratio compares what you pay today for each unit of earnings to what those earnings are right now. For a business like Ping An Healthcare and Technology that is tied to online healthcare services and related consumer offerings, this metric gives a quick sense of how much of its future profit story the market is already pricing in.

Against similar companies followed in its peer group, Ping An Healthcare and Technology is described as good value with its 25.2x P/E sitting below a 41.5x peer average. That suggests the market is assigning a lower earnings multiple than many comparable stocks. At the same time, the stock is described as expensive versus the wider Hong Kong Consumer Retailing industry, where the average P/E is 20.6x, and also expensive against an estimated fair P/E of 12.8x.

Explore the SWS fair ratio for Ping An Healthcare and Technology.

Result: Price-to-earnings of 25.2x (OVERVALUED).

Still, Ping An Healthcare and Technology faces clear pressure if the GlobalCare rollout fails to gain traction or if competition in online medical services intensifies further.

Find out about the key risks to this Ping An Healthcare and Technology narrative.

Another View on Ping An Healthcare and Technology’s Valuation

The P/E screen paints Ping An Healthcare and Technology as expensive, yet the SWS DCF model points the other way. At a HK$6.35 share price against an estimated future cash flow value of HK$21.15, the stock is described as trading about 70% below that assessment. That gap raises a simple question: which signal deserves more weight, today’s earnings multiple or a long term cash flow view?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Ping An Healthcare and Technology for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 196 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If the split verdict on Ping An Healthcare and Technology’s valuation feels unresolved, consider moving quickly, testing the numbers yourself and weighing both sides. To see a concise breakdown of the trade off between potential upsides and the risks that investors are watching, start with these 3 key rewards and 1 important warning sign.

Looking for more investment ideas beyond Ping An Healthcare and Technology?

Do not stop at Ping An Healthcare and Technology. Fresh ideas can change your portfolio’s risk and reward balance faster than most investors expect.

• Target potential mispricings by scanning a focused list of companies that screen as attractively valued on key fundamentals through our 196 high quality undervalued stocks.
• Strengthen your income stream by reviewing businesses that combine higher yields with balance sheet support in the 159 dividend fortresses.
• Cut portfolio stress by concentrating on businesses that pass tough stability checks with the 226 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com